Immuno-oncology in Colorectal Cancer: A Sneak Peek
Dr David J. Kerr reviews HDAC and immune checkpoint inhibitors, therapies on the horizon for a subset of patients with colorectal cancers. (Source: Medscape Oncology)
Source: Medscape Oncology - March 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Why the High CRC Rate in Latino--Genes, Stigma, or Other Factors?
Colorectal cancer is the second most common cause of cancer death in the Latino population. Drs John Marshall and Marcia Cruz-Correa discuss which factors are at play. (Source: Medscape Oncology)
Source: Medscape Oncology - March 20, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Next Level of Immunotherapy to Include Combos with Vaccines & amp; Chemotherapy in Multiple Disease States
James L. Gulley, MD, PhD of National Cancer Institute at the National Institutes of Health discusses the new research regarding immunotherapies. He states that specifically in colorectal cancer, healt...
Author: ASCO-SITC2017
Added: 03/06/2017 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2017 Category: Cancer & Oncology Source Type: podcasts
Recurrent Colon Cancer: Location, Location, Location
Tumor location, whether on the right or left side of the colon, seems to affect the prognosis and aggressiveness of recurrent colorectal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - February 27, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Molecular Tests For Treatment Approach in a Newly Diagnosed CRC Patient
John L. Marshall, MD of Lombardi Comprehensive Cancer Center gives his perspective on how to choose molecular tests for treating newly diagnosed colorectal cancer patients at the 2017 Gastrointestinal...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
How to Use Both TAS-102 and Regorafenib in Metastatic CRC Patients
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his perspective on how to use both TAS-102 and regorafenib for patients with metastatic colorectal cancer at the 2017 Gastrointesti...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Which Molecular Tests are Most Important for Treating CRC Patients
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute gives his take on choosing molecular tests for treatment for newly diagnosed Colorectal Cancer patients at the 2017 Gastrointestinal Canc...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Use of Immunotherapy for Existing Colorectal Cancer Treatment
Philip Agop Philip, MD, PhD, FRCP of Karmanos Cancer Institute discusses how healthcare professionals are integrating immunotherapy in existing treatment regimens for patients with colorectal cancer a...
Author: obr
Added: 01/26/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 26, 2017 Category: Cancer & Oncology Source Type: podcasts
Using Both TAS-102 and Regorafenib in Metastatic CRC Patients
Alan P. Venook, MD, FASCO of Helen Diller Family Comprehensive Cancer Center gives his perspective on how to use both TAS-102 and regorafenib in patients with metastatic colorectal cancer at the 2017 ...
Author: obr
Added: 01/25/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2017 Category: Cancer & Oncology Source Type: podcasts
Outcomes of Randomized Phase 2 Study in BRAF-Mutated CRC Patients
Howard S. Hochster, MD of Yale Cancer Center discusses the outcomes of the randomized phase 2 study in BRAF-mutated patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO...
Author: obr
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
Genetic Profiling in Treatment Approach for Patients with CRC
Howard S. Hochster, MD of Yale Cancer Center discusses how genetic profiling has changed the treatment approach for patients with colorectal cancer at the 2017 Gastrointestinal Cancers Symposium (ASCO...
Author: obr
Added: 01/24/2017 (Source: Oncology Tube)
Source: Oncology Tube - January 24, 2017 Category: Cancer & Oncology Source Type: podcasts
